EndoChoice
A platform-technology company that provides devices, diagnostics, infection control and imaging for specialists treating a wide range of gastrointestinal diseases.
News
New Study Shows Full Spectrum Endoscopy Procedure Reduces The ‘Miss Rate’ of Adenomas During Colonoscopy
EndoChoice’s Fuse system receives FDA 510(k) Clearance.
SEMDA 2013: A CEO’s journey is roller coaster ride of successes and failures
Just what does it take to be a CEO of a successful med-tech startup? What does the journey look like for a CEO that has made it through the process of taking an idea and building a product and business around it? Those questions were answered during the CEO Roundtable at the Southeastern Medical Device Conference (SEMDA), which included the CEO of River Cities Capital Funds’ portfolio company EndoChoice.
EndoChoice Announces Merger with Peer Medical and Secures $43 Million
To expand its line of endoscopy technology, River Cities’ portfolio company EndoChoice will merge with Peer Medical.
The Story of EndoChoice: From Zero to #6 on the Inc. 500 in Three Years
SEMDA’s November 29 meeting to feature EndoChoice CEO and founder Mark Gilreath.
EndoChoice Inc., Named as One of America’s Fastest Growing Companies
EndoChoice ranks #6 in the health segment on the Inc. 500.
